Exceptional Response to Dacarbazine in Uterine Leiomyosarcoma With Homozygous
BRCA2
Deletion Highlights the Role of Homologous Recombination in Response to DNA Damage From Alkylating Agents
JCO Precis Oncol
.
2018 Nov:2:1-6.
doi: 10.1200/PO.18.00131.
Authors
Matthew A Ingham
1
,
Julia E McGuinness
1
,
Kevin Kalinsky
1
,
Gary K Schwartz
1
Affiliation
1
All authors: Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY.
PMID:
35135137
DOI:
10.1200/PO.18.00131
No abstract available